We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Threshold Lowered for Lead Poisoning In Children

By LabMedica International staff writers
Posted on 28 May 2012
The threshold level for defining lead poisoning in children has been lowered for the first time in 20 years. More...


High levels of lead in a child's blood can cause coma, convulsions, and death, and even low levels can cause decreased intelligence and impaired hearing.

The US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) has announced officially that the new reference value for lead poisoning was based on the population of US children aged 1-5 years whose blood lead levels are in the highest 2.5% of children tested. The threshold level for defining lead poisoning in children has been lowered from 10 µg/dL down to 5 µg/dL.

About 450,000 children aged 1-5 years living in the US have blood lead levels above the new standard, up from 250,000 with lead levels greater than 10 µg/dL of blood under the previous threshold. The leading sources of lead exposure to US children are lead-based paint, which was banned for use in housing in 1978, and lead-contaminated dust.

Since fingerstick samples can be contaminated during collection of the specimen, an initial elevated result obtained by a fingerstick sample should be repeated with a venous test for confirmation, usually within a week to a month after the first test. Follow-up testing is then used to monitor the persistence of an elevated blood lead test and the original recommendation was whenever a child's blood lead level is higher than 10 µg/dL. Those with persistent lead levels above 15-19 µg/dL that remain elevated for three months or more and those with initial tests greater than 20 µg/dL should have their home surroundings evaluated to determine the source of the lead exposure.

Christopher J. Portier, PhD, the director of the CDC's National Center for Environmental Health, said, "Parents can act without the CDC being there.” He suggested they could contact local health departments for testing of paint and dust to detect high lead levels. The CDC also recommends parents regularly wash children's hands and toys, and wet-mop floors and windowsills, in addition to preventing children from playing in bare soil.

Related Links:

US Centers for Disease Control and Prevention




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.